Insmed Incorporated

Healthcare

NASDAQ:INSM · NASDAQ Global Select

Market Cap $21.27B Beta 0.77 P/E (TTM) -17.9

$98.11 +1.44%

+$1.39 today

52W Low $90.39High $212.75

Vol 2.93M · Avg 3.15M

EPS (TTM)-$5.49

Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+1.14%

Period High

$211.41

Period Low

$91.88

Latest

$97.98

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Cardinal Health, Inc.

NYSE:CAH

$52.51B

Takeda Pharmaceutical Company Limited

NYSE:TAK

$50.48B

Humana Inc.

NYSE:HUM

$45.30B

Haleon plc

NYSE:HLN

$40.37B

Agilent Technologies, Inc.

NYSE:A

$36.53B

Alcon Inc.

NYSE:ALC

$32.53B

IQVIA Holdings Inc.

NYSE:IQV

$29.94B

GE HealthCare Technologies Inc.

NASDAQ:GEHC

$29.60B

BeOne Medicines Ltd.

NASDAQ:ONC

$28.29B

ResMed Inc.

NYSE:RMD

$28.10B

What is the latest INSM filing?

The latest filing shown is 4 dated Jun 10, 2026.

How many recent filings does INSM have?

Intrinsic Alpha currently shows 20 recent filings for INSM.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.